A Turbulent Year in the Publishing World
In 2017, scientists, regulators, and publishers clashed in a series of lawsuits, boycotts, mass resignations, and more.
Send us a link
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.
One Way to Fix Reproducibility Problems: Train Scientists Better
Leonard Freedman, president of the Global Biological Standards Institute, discusses the causes of irreproducible science and his latest effort to spread best practices.
Share Your Data
An analysis of a collection of open-access datasets quantifies their benefit to the scientific community.
How Journals Treat Papers from Researchers Who Committed Misconduct
Nature Plants explains how it handled a manuscript coauthored by Patrice Dunoyer, a biologist with multiple retractions to his name.
Fraud Scheme Uncovered in China
The Chinese government finds almost 500 researchers guilty of misconduct in relation to a recent spate of retractions from a cancer journal.
On Blacklists and Whitelists
Experts debate how best to point researchers to reputable publishers and steer them away from predatory ones.
Making Public Data Public
Computational scientists develop a system for spotting data overdue for public release, and end up getting hundreds of open-access datasets corrected.
The Frustrating Process of Manuscript Submission
We suggest a centralized facility for submitting to journals—one that would benefit scientists and not only publishers.
Publication Ban Affects Former Collaborators
When firing Allen Braun, the NIDCD also barred his colleagues from publishing data collected over a 25-year period.
Brain Prize Winners Announced
Three UK neuroscientists jointly win the €1 million European Brain Prize for their work on memory.
×